This is a StreetInsider.com Premium Only Page

Exact Sciences (EXAS) – Press Releases

Apr 15, 2024 06:00 AM Exact Sciences Names Aaron Bloomer as New Chief Financial Officer

Apr 11, 2024 06:00 AM Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes

Apr 8, 2024 12:05 PM Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024

Apr 8, 2024 06:00 AM Exact Sciences Schedules First Quarter 2024 Earnings Call

Apr 4, 2024 06:05 AM Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment

Mar 28, 2024 06:00 AM Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer

Mar 27, 2024 08:05 AM Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner

Mar 13, 2024 05:03 PM The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study

Mar 7, 2024 07:59 AM Exact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon Cancer

Feb 26, 2024 06:00 AM Exact Sciences to Participate in March Investor Conference

Feb 21, 2024 04:05 PM Exact Sciences Announces Fourth Quarter 2023 Results

Feb 1, 2024 06:00 AM Exact Sciences Schedules Fourth Quarter 2023 Earnings Call

Jan 7, 2024 04:30 PM Exact Sciences Announces Preliminary Fourth Quarter 2023 Results

Jan 2, 2024 06:00 AM Exact Sciences to participate in J.P. Morgan Healthcare Conference

Dec 12, 2023 05:31 PM Madryn Asset Management, a Top Shareholder of SomaLogic, Issues Letter Regarding Opposition to the Company’s Proposed Merger with Standard BioTools

Dec 7, 2023 08:05 AM Exact Sciences Awards Grants to 23 Organizations Focused on Increasing Colorectal Cancer Screenings

Nov 30, 2023 04:05 PM Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients

Nov 17, 2023 07:10 AM Exact Sciences Files Patent Infringement Lawsuit Against Geneoscopy

Nov 1, 2023 04:05 PM Exact Sciences Announces Third-Quarter 2023 Results

Nov 1, 2023 06:00 AM Exact Sciences to participate in November investor conferences

Oct 22, 2023 03:00 PM Next-Generation Cologuard® Test Demonstrates High Sensitivity and Specificity in Pivotal BLUE-C Study, Significantly Outperforming Fecal Immunochemical Testing (FIT) for Cancer and Precancer Detectio

Oct 20, 2023 06:08 PM Exact Sciences Advances Early Cancer Detection and Precision Oncology Programs with Data Presentations at ESMO 2023 Annual Congress

Oct 9, 2023 06:00 AM Exact Sciences schedules third quarter 2023 earnings call

Oct 9, 2023 05:58 AM Exact Sciences to Present Late-Breaking Data from Pivotal BLUE-C Study on Next-Generation Cologuard at ACG 2023

Sep 12, 2023 08:35 AM Agilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience

Sep 1, 2023 06:00 AM Exact Sciences to participate in September investor conference

Aug 30, 2023 07:30 AM Exact Sciences Lab and OncoExTra Test Selected by National Cancer Institute for ComboMATCH Clinical Trials

Aug 21, 2023 07:57 AM Not a Wall, But an Obstacle Course: New Findings Reveal Why 45-Year-Olds Are Avoiding Colorectal Cancer Screenings

Aug 1, 2023 04:05 PM Exact Sciences Announces Second-Quarter 2023 Results

Jul 10, 2023 06:00 AM Exact Sciences schedules second quarter 2023 earnings call

Jun 21, 2023 07:14 AM Exact Sciences Advances Innovative Cancer Technologies and Approaches Through Visionary Collaborations

Jun 20, 2023 04:05 PM Next-generation Cologuard Test Demonstrates 94 Percent Sensitivity for Colorectal Cancer at 91 Percent Specificity, Raising the Bar in Non-invasive Screening

Jun 1, 2023 08:00 AM EXACT SCIENCES EARNS 2023 GREAT PLACE TO WORK® CERTIFICATION™

Jun 1, 2023 06:00 AM Exact Sciences to participate in June investor conferences

May 26, 2023 06:58 AM Exact Sciences Presents New Long-Term Patient Outcomes in Multi-Cancer Early Detection and Breast Cancer Recurrence Testing at ASCO® 2023

May 17, 2023 07:00 AM EXACT SCIENCES AWARDS GRANTS TO 18 ORGANIZATIONS FOCUSED ON INCREASING COLORECTAL CANCER SCREENINGS

May 9, 2023 04:05 PM Exact Sciences Announces First Quarter 2023 Results

May 9, 2023 06:37 AM Exact Sciences Extends Leadership in Colorectal Cancer Screening with New Data Presented at Digestive Disease Week® Annual Meeting

May 1, 2023 06:00 AM Exact Sciences to participate in May investor conference

Apr 12, 2023 03:07 PM Exact Sciences Presents Advancements in Cancer Detection at American Association for Cancer Research® 2023 Annual Meeting

Apr 10, 2023 06:00 AM Exact Sciences schedules first quarter 2023 earnings call

Feb 23, 2023 09:29 AM Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes

Feb 22, 2023 06:00 AM Exact Sciences to participate in March investor conferences

Feb 21, 2023 04:05 PM Exact Sciences Announces Fourth Quarter 2022 Results

Feb 7, 2023 08:29 AM Exact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S.

Feb 1, 2023 06:00 AM Exact Sciences schedules fourth quarter 2022 earnings call

Jan 8, 2023 03:45 PM Exact Sciences Announces Preliminary Fourth Quarter 2022 Results

Jan 3, 2023 06:00 AM Exact Sciences to participate in J.P. Morgan Healthcare Conference

Dec 20, 2022 10:13 AM Medicare and Insurance Policy Updates in 2023 Will Improve Cancer Screening Access by Removing Patient Colonoscopy Cost Following a Positive Cologuard Test

Dec 9, 2022 10:05 AM Exact Sciences Presents First Time Data Detailing Ability to Predict Radiation Therapy Benefit in Breast Cancer Patients